| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8647175 | Multiple Sclerosis and Related Disorders | 2018 | 4 Pages |
Abstract
Recurrent vaginitis should be taken into account as a possible adverse effect causing discomfort during long-term natalizumab treatment. Simple measures, such as probiotic administration and meticulous local hygiene, can provide adequate relief for such patients.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Genetics
Authors
Georgios-Marios Makris, Jonida Mene, Alexandros Fotiou, Vasileia Xyla, Marco-Johannes Battista, Theodoros N. Sergentanis,